Published within
|«
«
|
1
|
2
|
3
|
4
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
Nycomed International Management (Nycomed), a Takeda company, is engaged in the development and marketing of branded medicines primarily in the areas of gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. The company has operations in 50 countries worldwide. It primarily operates in Europe, the US, Latin America, South Africa, Canada and Russia. The company is headquartered in Zurich, Switzerland and employed 12,506 people as of December 31, 2010.
Published By MarketLine
|
20 Dec 2011 |
$175
|
Company Profile
|
Bayer (or 'the group') is a Germany-based global chemical and pharmaceutical group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. It is headquartered in Leverkusen, Germany, and employed about 111,800 people as of December 31, 2011.
Published By MarketLine
|
15 Jun 2012 |
$175
|
Company Profile
|
Sandoz International GmbH (Sandoz or 'the company'), the generic business division of Novartis, is the second largest generic manufacturer (in terms of revenues) in the world. It is engaged in the development, manufacture and marketing of generic medicines as well as pharmaceutical and biotechnological active ingredients. The company manufactures more complex generics in different delivery systems including patches, injectables and inhalers. It has operations in more than 130 countries. It is headquartered
Published By MarketLine
|
22 Jun 2012 |
$175
|
Company Profile
|
Omega Pharma (Omega or the 'company') is a privately-held company engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. The company provides cough and cold therapies; pain relief products; vitamins, minerals, and nutritional supplements; products for gastro-intestinal disorders; skin care products; anti-allergy products; and smoking cessation therapies. It also offers anti-mosquito products, slimming products, and home diagnostics. The company primarily operates
Published By MarketLine
|
25 Jun 2012 |
$175
|
Company Profile
|
Alcon, Inc. (Alcon or 'the company'), a business division of Novartis, is a global medical specialty company focused on eye care. It is engaged in the development, manufacture and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products for the treatment of eye disorders. Alcon markets its products across 180 countries and operates in over 75 countries. The company primarily operates in the US, Japan and Switzerland. It is headquartered in Hunenberg, Switzerland and employed...
Published By MarketLine
|
28 Jun 2012 |
$175
|
Company Profile
|
Galenica (or 'the group') is engaged in the development, manufacture and marketing of pharmaceutical products. It also operates pharmacies, and provides logistical and database services. The group has its presence in Europe, America and other countries. It is headquartered in Berne, Switzerland and employed 5,926 people as on December 31, 2011.
Published By MarketLine
|
17 Jul 2012 |
$175
|
Company Profile
|
F. Hoffmann-La Roche Ltd (Roche or 'the group') is one of the leading research-focused healthcare groups in the world. It is engaged in the discovery, development and commercialization of innovative diagnostic and therapeutic products. Roche is headquartered in Basel, Switzerland, and employed 80,129 people as of December 31, 2011.
Published By MarketLine
|
20 Jul 2012 |
$175
|
Company Profile
|
Almirall S.A. (Almirall or 'the group') formerly Laboratorios Almirall, is one of the leading pharmaceutical groups in Spain. The group researches, develops, manufactures and commercializes proprietary drugs as well as licensed products. Its products are sold in over 70 countries, with a direct presence in Europe and Latin America. Almirall is headquartered in Barcelona, Spain, and employed about 2,765 people at the end of December 2011.
Published By MarketLine
|
25 Jul 2012 |
$175
|
Company Profile
|
AstraZeneca PLC (AstraZeneca or 'the company') is a UK-based global biopharmaceutical company. The company is engaged in developing, manufacturing, and marketing prescription pharmaceuticals in the area of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation, and infection. AstraZeneca operates in the Americas, Europe and Asia. The company is headquartered in London, the UK and employed about 59,800 people as of December 31, 2011.
Published By MarketLine
|
31 Jul 2012 |
$175
|
Company Profile
|
Novartis AG (Novartis or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products, preventive vaccines, diagnostic tools and consumer health products. The company operates in more than 140 countries across the globe. It is headquartered in Basel, Switzerland, and employed 123,686 people as of December 31, 2011.
Published By MarketLine
|
28 Sep 2012 |
$175
|
|«
«
|
1
|
2
|
3
|
4
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.